Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Ratings
Promising Clinical Developments and Strategic Partnerships Propel Nanobiotix to a Buy Rating
14d ago
NBTX
Premium
Ratings
Nanobiotix’s Strategic Advancements and Financial Strength Bolster Buy Rating
19d ago
NBTX
Premium
Ratings
Nanobiotix’s NBTXR3: Promising Survival Benefits and Strategic Collaborations Justify Buy Rating
1M ago
NBTX
Premium
Company Announcements
Nanobiotix SA’s Positive Earnings Call Highlights Strategic Growth
2M ago
Premium
The Fly
Nanobiotix price target lowered to $8 from $12 at Guggenheim
2M ago
NBTX
Premium
Ratings
Nanobiotix’s Promising Future: Buy Rating Backed by Data-Rich 2025 and Strategic Advancements
2M ago
NBTX
Premium
Ratings
Nanobiotix: Strategic Partnerships and Clinical Advancements Drive Buy Rating
2M ago
NBTX
Premium
Ratings
Positive Clinical Data and Strategic Partnerships Drive Buy Rating for Nanobiotix
2M ago
NBTX
Premium
Ratings
Nanobiotix’s Strategic Partnership and Financial Stability Justify Buy Rating
3M ago
NBTX
Premium
Ratings
Nanobiotix’s Strategic and Financial Strength Bolstered by Janssen Licensing Agreement and Milestone Payments
3M ago
NBTX
Premium
Ratings
Strategic Licensing Amendment with Janssen Bolsters Nanobiotix’s Financial Outlook and Justifies Buy Rating
3M ago
NBTX
Premium
The Fly
Nanobiotix amends global licensing agreement with Janssen Pharmaceutica
3M ago
JNJ
NBTX
Premium
The Fly
Nanobiotix files $200M mixed securities shelf
3M ago
NBTX
Premium
The Fly
Nanobiotix files to sell 5.62M ordinary shares for holders
3M ago
NBTX
Premium
The Fly
Nanobiotix downgraded to Neutral from Buy at UBS
4M ago
NBTX
Premium
The Fly
Nanobiotix doses first patient in CONVERGE study
5M ago
JNJ
NBTX
Premium
The Fly
Nanobiotix completes dose escalation-expansion parts of NBTXR3 in PC
6M ago
NBTX
Premium
The Fly
Nanobiotix initiated with a Buy at Guggenheim
10M ago
NBTX
Premium
The Fly
Nanobiotix initiated with a Buy at Guggenheim
10M ago
NBTX
Premium
The Fly
Nanobiotix initiated with a Buy at Stifel
12M ago
NBTX
Premium
The Fly
Nanobiotix announces new data from Study 1100
1y ago
NBTX
Premium
The Fly
Nanobiotix provides update on NBTXR3 collaboration
1y ago
JNJ
NBTX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
